AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.11) by 63.64 percent. This is a 60 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $80.915 million which beat the analyst consensus estimate of $80.500 million by 0.52 percent. This is a 6.87 percent increase over sales of $75.711 million the same period last year.